Intra-Cellular Therapies, Inc. Public Market Comparables
Find the most relevant public market comparables for Intra-Cellular Therapies, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
A biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological disorders. The company develops novel drugs for treating diseases of the central nervous system, leveraging proprietary chemistry platforms to develop drugs for neurodegenerative diseases.
Business Model
Discovery, development, and commercialization of small molecule drugs for neuropsychiatric and neurological disorders.
Target Customers
Patients with neuropsychiatric and neurological disorders, healthcare providers, and health systems.
Specific Focus
Developing treatments for complex psychiatric and neurologic diseases using an intracellular approach.
Location
New York, New York
CEO
Sharon Mates
Industry
Life sciences
Sub Sector
Biotechnology
3yr Revenue Growth
1,936%
Public Market Comparables
Below are the key valuation metrics for companies similar to Intra-Cellular Therapies, Inc. in the Pharmaceuticals sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Intra-Cellular Therapies, Inc.? Our platform provides detailed analysis of Intra-Cellular Therapies, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Intra-Cellular Therapies, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Intra-Cellular Therapies, Inc. Compset
As a leading player in the Life sciences industry within the Pharmaceuticals sector, Intra-Cellular Therapies, Inc. operates in the specialized Biotechnology sub-sector. Understanding how Intra-Cellular Therapies, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biotechnology space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
BioCryst Pharmaceuticals Inc.
Biotechnology • Life sciences
BioCryst Pharmaceuticals Inc. is a biotechnology company that designs, optimizes, and develops small molecule drugs to block critical enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary angioedema.
Gyre Therapeutics, Inc.
Pharmaceuticals & Biotech • Life sciences
A commercial-stage biopharmaceutical company focused on the research, development, manufacturing, and commercialization of drugs for organ fibrosis. They develop and commercialize small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, specifically organ fibrosis. The company has commercial-stage products and a diverse pipeline of drug candidates, operating in both the US and China.
Validere Technologies
Information Technology • Software & services
Validere is an all-in-one commodity management platform for the energy industry, integrating operations, commercial, and ESG data. It provides real-time visibility into the true composition and quality of oil and gas, enabling operational efficiencies and high-margin marketing and supply decisions. The platform uses AI and machine learning to detect and quantify methane emissions, supporting regulatory reporting and corporate emissions initiatives.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Intra-Cellular Therapies, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free